A region-specific soil health assessment protocol and evaluation for Sub-Saharan Africa - Nature

Building the foundations for an AI-ready economy can contribute to turning Africa’s growth into more jobs and better opportunities for the region's rapidly growing labor force WASHINGTON, October 6, 2026 — Sub-Saharan Africa’s economy remains resilient despite geopolitical tensions, climate shocks, declining development assistance, and fiscal pressures. Growth in the region is projected to rise from 4.1% in 2025 to 4.3% in 2026, 0.3 percentage points above the April 2026 forecast, according to the latest edition of the Africa Economic Update, the World Bank Group’s biannual economic report for the region.

When Naoko Takahashi crossed the finish line at the 2001 Berlin Marathon, her expression turned from agony to ecstasy. The digits on the giant clock above her clicked from 2:19:45 to 2:19:46 but, after straining for so long to chase time and history, the Japanese runner glanced first at her wristwatch and then at the face of her coach before fully realising what she had done.

Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.